Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-12-29

Clinical Trial Update: The Effect of Chlorhexidine on the Oral and Lung Microbiota in Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial investigating how chlorhexidine affects oral and lung microbiota in chronic obstructive pulmonary disease (COPD); study completed with results pos…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine (chlorhexidine)

Snippet

Sponsor: University of Minnesota | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED | Results posted: 2020-12-29